ketanserin has been researched along with Reperfusion Injury in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoni, S | 1 |
| Ghizzardi, P | 1 |
| Cattaruzza, F | 1 |
| Ballabeni, V | 1 |
| Impicciatore, M | 1 |
| Tognolini, M | 1 |
| Lagrasta, CA | 1 |
| Barocelli, E | 1 |
1 other study available for ketanserin and Reperfusion Injury
| Article | Year |
|---|---|
Evidence for the involvement of 5-HT2A receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice.
Topics: Amphetamines; Animals; Capillary Permeability; Female; Gastrointestinal Transit; Intestines; Ketanse | 2007 |